[go: up one dir, main page]

BRPI0408320A - compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder - Google Patents

compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder

Info

Publication number
BRPI0408320A
BRPI0408320A BRPI0408320-2A BRPI0408320A BRPI0408320A BR PI0408320 A BRPI0408320 A BR PI0408320A BR PI0408320 A BRPI0408320 A BR PI0408320A BR PI0408320 A BRPI0408320 A BR PI0408320A
Authority
BR
Brazil
Prior art keywords
compound
treating
disorder
pharmaceutical composition
affective disorder
Prior art date
Application number
BRPI0408320-2A
Other languages
Portuguese (pt)
Inventor
Benny Bang-Andersen
Friedrich Kroll
Jan Kehler
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BRPI0408320A publication Critical patent/BRPI0408320A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
BRPI0408320-2A 2003-04-04 2004-04-02 compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder BRPI0408320A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46026503P 2003-04-04 2003-04-04
DKPA200300519 2003-04-04
PCT/DK2004/000241 WO2004087155A1 (en) 2003-04-04 2004-04-02 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
BRPI0408320A true BRPI0408320A (en) 2006-03-07

Family

ID=33132908

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408320-2A BRPI0408320A (en) 2003-04-04 2004-04-02 compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder

Country Status (18)

Country Link
US (1) US20060293360A1 (en)
EP (1) EP1635828B1 (en)
JP (1) JP2006522027A (en)
AT (1) ATE392896T1 (en)
AU (1) AU2004226837A1 (en)
BR (1) BRPI0408320A (en)
CO (1) CO5640133A2 (en)
DE (1) DE602004013314T2 (en)
DK (1) DK1635828T3 (en)
ES (1) ES2303062T3 (en)
HR (1) HRP20080262T3 (en)
MX (1) MXPA05010627A (en)
NO (1) NO20055206L (en)
NZ (1) NZ540891A (en)
PL (1) PL1635828T3 (en)
PT (1) PT1635828E (en)
SI (1) SI1635828T1 (en)
WO (1) WO2004087155A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1626720B1 (en) 2003-04-04 2008-09-03 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
CA2656057C (en) * 2006-06-16 2012-10-02 H. Lundbeck A/S Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
TWI432194B (en) * 2007-03-20 2014-04-01 Lundbeck & Co As H Novel therapeutic uses of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine
ES2397247T3 (en) 2008-11-14 2013-03-05 Theravance, Inc. Crystalline form of a compound 4- [2- (2-fluorophenoxymethyl) phenyl] piperidine
TWI396689B (en) 2008-11-14 2013-05-21 Amgen Inc Pyrazine derivatives as phosphodiesterase 10 inhibitors
TW201030001A (en) 2008-11-14 2010-08-16 Amgen Inc Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
WO2010077992A1 (en) 2008-12-17 2010-07-08 Amgen Inc. Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
EP2523945A1 (en) * 2010-01-11 2012-11-21 Theravance, Inc. 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
EP2550252B1 (en) * 2010-03-22 2015-05-06 Theravance Biopharma R&D IP, LLC 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
WO2011133790A2 (en) * 2010-04-22 2011-10-27 Theravance, Inc. Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
EE200100441A (en) * 1999-02-23 2002-12-16 Pfizer Products Inc. Monoamine reuptake inhibitors for the treatment of central nervous system disorders
PL355289A1 (en) * 1999-10-13 2004-04-05 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS

Also Published As

Publication number Publication date
EP1635828A1 (en) 2006-03-22
JP2006522027A (en) 2006-09-28
US20060293360A1 (en) 2006-12-28
HRP20080262T3 (en) 2009-04-30
PL1635828T3 (en) 2008-10-31
SI1635828T1 (en) 2008-08-31
WO2004087155A1 (en) 2004-10-14
NZ540891A (en) 2008-07-31
EP1635828B1 (en) 2008-04-23
PT1635828E (en) 2008-07-01
DE602004013314D1 (en) 2008-06-05
ES2303062T3 (en) 2008-08-01
MXPA05010627A (en) 2005-12-12
NO20055206L (en) 2005-11-04
CO5640133A2 (en) 2006-05-31
ATE392896T1 (en) 2008-05-15
AU2004226837A1 (en) 2004-10-14
DK1635828T3 (en) 2008-08-11
DE602004013314T2 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
BR0212733A (en) Compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder
CY1108464T1 (en) Piperidine 4- (2-phenylsulfanyl-phenyl) derivative of piperidine as serotonin re-uptake inhibitors
BRPI0408320A (en) compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder
BRPI0408453A (en) compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder
DE60207857D1 (en) NEW HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE
BRPI0408647A (en) compound, pharmaceutical composition, use of a compound, and method for treating an affective disorder
BR0308870A (en) Compound, pharmaceutical composition, process for preparing a compound, use of a compound, and method for treating a thrombotic disorder in a patient
ATE423772T1 (en) MORPHOLINE DERIVATIVES AS INHIBITORS OF NOREPINEPHRINE REUPSTRUCTION
EA200501580A1 (en) DERIVATIVES OF 4- (2-PHENYLOXYPHENYL) PIPERIDINE OR -1,2,3,6- TETRAHYDROPYRIDINE AS SEROTONIN RETURN CAPTURE
MY141048A (en) Morpholine derivatives as norepinephrine reuptake inhibitors
BRPI0409768A (en) compound, use of compound, pharmaceutical composition, method for treating and / or preventing cancer, and process for preparing the compound
HRP20070123A2 (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.